Cargando…

Monographs for medicines on WHO’s Model List of Essential Medicines

OBJECTIVE: To raise awareness about the importance of public pharmaceutical standards, identify if and, if so, where current pharmacopeias are falling short in the development of new and complete monographs and foster collaboration among the various pharmacopeias, to prioritize, develop and make ava...

Descripción completa

Detalles Bibliográficos
Autores principales:	Roth, Lukas, Adler, Melissa, Jain, Tanvi, Bempong, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	World Health Organization 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5996216/ https://www.ncbi.nlm.nih.gov/pubmed/29904220 http://dx.doi.org/10.2471/BLT.17.205807

Ejemplares similares

NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions
por: Di Cesare, Mariachiara, et al.
Publicado: (2020)

WHO monographs on selected medicinal plants.
Publicado: (1999)

A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010)

Disparities in access to fertility care: who’s in and who’s out
por: Galic, Isabel, et al.
Publicado: (2020)

Estimation of cost-based prices for injectable medicines in the WHO Essential Medicines List
por: Gotham, Dzintars, et al.
Publicado: (2019)

Estimated costs of production and potential prices for the WHO Essential Medicines List
por: Hill, Andrew M, et al.
Publicado: (2018)

Baseline assessment of WHO’s target for both availability and affordability of essential medicines to treat non-communicable diseases
por: Ewen, Margaret, et al.
Publicado: (2017)

Who’s Who
Publicado: (2022)

Who’s in and Who’s Out? Selection Bias in Aging Research
por: Mayeda, Elizabeth Rose, et al.
Publicado: (2020)

Selection of WHO-recommended essential medicines for non-communicable diseases on National Essential Medicines Lists
por: Jarvis, Jordan D., et al.
Publicado: (2019)

Revising the WHO Essential Medicines List for paediatric rheumatology
por: Scott, Christiaan, et al.
Publicado: (2021)

POCKET MONOGRAPHS ON PRACTICAL MEDICINE
Publicado: (1935)

Comparative Analysis of ADR on China's National Essential Medicines List (2015 Edition) and WHO Model List of Essential Medicines (19th Edition)
por: Zheng, Fangfang, et al.
Publicado: (2018)

Medicine Monographs, Vol. IV, Calorimetry in Medicine
Publicado: (1926)

Revising the WHO Essential Medicines List for paediatric rheumatology update
por: Slamang, Waheba, et al.
Publicado: (2022)

Introduction to Who’s Who: EBCOG
por: Van Wiemeersch, J.
Publicado: (2010)

A quantitative comparison of essential cardiovascular medicines from countries in the Southern African Development Community to the WHO model essential medicines list
por: Naicker, Ian, et al.
Publicado: (2022)

Medicine Monographs, Vol. V. Dyspnœa
Publicado: (1926)

Medicine Monographs. Vol. VI. Insulin
Publicado: (1926)

Medicine Monographs. Volume XIV, Epilepsy
Publicado: (1929)

Longevity or hypoxia: who’s driving?
por: Pamenter, Matthew E., et al.
Publicado: (2019)

Who’s got TALENT?
por: Joannah Caborn Wengler
Publicado: (2012)

Global status of essential medicine selection: a systematic comparison of national essential medicine lists with recommendations by WHO
por: Piggott, Thomas, et al.
Publicado: (2022)

Essential medicines for mental disorders: comparison of 121 national lists with WHO recommendations
por: Todesco, Beatrice, et al.
Publicado: (2023)

Back to the ‘essence’ of medical treatment in oncology: the 2015 WHO Model List of Essential Medicines
por: Eniu, Alexandru, et al.
Publicado: (2016)

The “Square Box”: Therapeutic Equivalence as a Foundation of the WHO Model List of Essential Medicines
por: Cappello, Bernadette, et al.
Publicado: (2020)

National adaptation and implementation of WHO Model List of Essential Medicines: A qualitative evidence synthesis
por: Peacocke, Elizabeth F., et al.
Publicado: (2022)

Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015–2021
por: Zhou, Yue, et al.
Publicado: (2023)

Community Vs. hospital HIV testing sites in Jerusalem, Israel - who’s tested and who’s at risk?
por: Atias, Dor, et al.
Publicado: (2020)

Medicine Monographs. Vol. VII. Lead Poisoning
Publicado: (1926)

Using the WHO Essential Medicines List to Assess the Appropriateness of Insurance Coverage Decisions: A Case Study of the Croatian National Medicine Reimbursement List
por: Jeličić Kadić, Antonia, et al.
Publicado: (2014)

Can Drosophila melanogaster tell who’s who?
por: Schneider, Jonathan, et al.
Publicado: (2018)

Who’s afraid of response bias?
por: Peters, Megan A. K., et al.
Publicado: (2016)

Rehabilitation in the context of WHO’s mandate
por: Ghebreyesus, Tedros Adhanom
Publicado: (2022)

Cool, but who’s going to pay for that
por: CERN. Geneva
Publicado: (2011)

Withdrawn medicines included in the essential medicines lists of 136 countries
por: Charles, Onella, et al.
Publicado: (2019)

Biologic medicine inclusion in 138 national essential medicines lists
por: Kraus, Raphaël, et al.
Publicado: (2021)

Protein quality control: the who’s who, the where’s and therapeutic escapes
por: Roth, Jürgen, et al.
Publicado: (2007)

Comparison of essential medicines lists in 137 countries
por: Persaud, Nav, et al.
Publicado: (2019)

The Role of Twitter in the WHO’s Fight against the Infodemic
por: Muñoz-Sastre, Daniel, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_hgkpku5r8168osj9an4qf3mhfc